References
Thomas RP, Hellmich MR, Townsend CM, Evers M (2003) Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissue. Endocrine Rev 24: 571–599
Arnold R (2007) Diagnosis and differential diagnosis of hypergastrinemia. Wien Klin Wochenschr 119: 564–569
Orlando LA, Lenard L, Orlando RC (2007) Chronic hypergastrinemia: causes and consequences. Dig Dis Sci 52: 2482–2489
Ruszniewski P, Dele Fave G, Cadiot G, Komminoth P, Chung D, Kos-Kudla Beata, Kianmanesh R, Hochhauser D, Arnold R, Ahlman H, Pauwels S, Kwekkeboom DJ, Rindi G (2006) Well-differentated gastric tumors/carinomas. Neuroendocrinology 84: 158–164
Niederle MB, Hackl Monika, Kaczirek K, Kaserer K, Niederle B (2007) The incidence of gastrointestinal neuroendocrine tumours in Austria – preliminary results of a prospective study. Langenbeck's Arch Surg 392 (in press)
Plöckinger U (2007) Diagnosis and treatment of gastric neuroendocrine tumors. Wien Klin Wochenschr 119: 570–572
Schindl M, Kaserer K, Niederle B (2001) Treatment of gastric neuroendocrine tumors. The necessity of a type-adapted treatment. Arch Surg 136: 49–54
Banasch M, Schmitz F (2007) Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors. Wien Klin Wochenschr 119: 573–578
Berna MJ, Hoffmann KM, Serrano J, Gibril F, Jensen RT (2006) Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature. Medicine 85: 295–330
Berna MJ, Hoffmann KM, Long SH, Serrano J, Gibril F, Jensen RT (2006) Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features. Medicine 85: 331–364
Klöppel G, Anlauf M (2007) Gastrinoma – morphological aspects. Wien Klin Wochenschr 119: 579–584
Weinhäusel A, Kaserer K, Vierhapper H, Niederle B, Haas OA (2002) Multiple endocrine neoplasia type 1 (MEN1) in Austria. Wien Klin Wochenschr 114: 252–257
Kaczirek K, Prager G, Schindl M, Kaserer K, Gessl A, Vierhapper H, Niederle B (2002) Multiple endocrine neoplasia 1 – current recommendations for diagnosis and treatment. Wien Klin Wochenschr 114: 258–266
Kann HP (2007) The value of endoscopic ultrasound in localizing gastrinoma. Wien Klin Wochenschr 119: 585–587
Klose KJ, Heverhagen JT (2007) Localisation and staging of gastrin producing tumours using cross-sectional imaging modalities. Wien Klin Wochenschr 119: 588–592
Behe M, Gotthart M, Behr TM (2007) Imaging of gastrinomas by nuclear medicine methods. Wien Klin Wochenschr 119: 593–596
Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, Heute D, Uprimny C, Kovacs P, Von Guggenberg E, Bale R, Virgolini IJ (2007) 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med 48: 508–518
Lorenz K, Dralle H (2007) Surgical treatment of sporadic gastrinoma. Wien Klin Wochenschr 119: 597–601
Bartsch D, Langer P, Rothmund M (2007) Surgical aspects of gastrinoma in multiple endocrine neoplasia type 1. Wien Klin Wochenschr 119: 602–608
Rothmund M, Carnaille B, Akerström G, Brunaud L, Fernandez-Crux L, Grant CS, Thompson NW, Scheuba C, Niederle B: Neuroendocrine pancreatic tumours: minimal consensus on endocopic surgical procedures. www.eses.cc/download/eses_workshop_synopsis_final.pdf
Auenhammer CJ, Göke B (2007) Medical treatment of gastrinomas. Wien Klin Wochenschr 119: 609–615
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Niederle, B. Hypergastrinemia – diagnosis and treatment. Wien Klin Wochenschr 119, 561–563 (2007). https://doi.org/10.1007/s00508-007-0897-x
Issue Date:
DOI: https://doi.org/10.1007/s00508-007-0897-x